BioFire Diagnostics, LLC recalls BioFire Joint Infection (JI) Panel REF
- Published
- 13 May 2026
- Units affected
- 106 kits (3,180 test)
- Agency
- FDA
- Country
- United States
The hazard
Contamination to in-vitro diagnostic test may result in false positives.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.
- Brand / company
- BioFire Diagnostics, LLC
- Codes / lots
- Lot #s:0883425,0878825/DI: 00815381020192
- Distribution
- Worldwide - US Nationwide distribution in the states of TX, NC, UT, MD and the countries of France, Italy, Germany, Spain, Belgium, Switzerland, United Kingdom, Netherlands, Poland, Austria, India, Finland, Czech Republic, Egypt, Lebanon, Morocco, Slovenia, Romania, Dominican Republic, Serbia.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 13 May 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.